Drug Shortage Report for PMS-ESCITALOPRAM
Report ID | 77559 |
Drug Identification Number | 02469251 |
Brand name | PHARMA-ESCITALOPRAM |
Common or Proper name | ESCITALOPRAM |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | ESCITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2019-03-01 |
Estimated end date | 2021-07-27 |
Actual end date | 2021-10-14 |
Shortage status | Resolved |
Updated date | 2021-10-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2021-10-15 | French | Compare |
v11 | 2021-10-15 | English | Compare |
v10 | 2021-06-18 | French | Compare |
v9 | 2021-06-18 | English | Compare |
v8 | 2020-09-18 | French | Compare |
v7 | 2020-09-18 | English | Compare |
v6 | 2019-07-31 | French | Compare |
v5 | 2019-07-31 | English | Compare |
v4 | 2019-05-09 | French | Compare |
v3 | 2019-05-09 | English | Compare |
v2 | 2019-03-04 | French | Compare |
v1 | 2019-03-04 | English | Compare |
Showing 1 to 12 of 12